Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...

A new milestone for CRISPR: prime editing enters clinical trials, enabling precise, programmable DNA changes for treating ...